HF
CANF

HRT Financial’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

HRT Financial’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60K Buy
+19,383
New +$80.1K ﹤0.01% 3431
2024
Q3 		– Sell
-540
Closed -$27K – 2478
2024
Q2 		$27K Buy
+540
New +$25.5K ﹤0.01% 1904
2022
Q1 		– Sell
-60
Closed -$15K – 3152
2021
Q4 		$15K Buy
+60
New +$16.5K ﹤0.01% 2983

Other funds holding CANF

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

HRT Financial's CANF Position: Q1 2026 in Review

HRT Financial opened a new position in Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2026: 19,383 shares worth $60K. The stake represents ﹤0.01% of the portfolio and ranks #3431 among its holdings. This is a return to the name: HRT Financial previously reported a position in CANF as recently as Q2 2024.

HRT Financial first reported a position in CANF in Q4 2021 and has held it in 3 quarters since. 14 funds tracked by Wall St. Rank hold CANF as of Q1 2026.

  • HRT Financial held 19,383 shares of Can-Fite BioPharma American Depositary Shares worth $60K as of Q1 2026.
  • Can-Fite BioPharma American Depositary Shares was a new HRT Financial position in Q1 2026.
  • Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3431 holding.
  • HRT Financial first reported a position in Can-Fite BioPharma American Depositary Shares in Q4 2021 and has held it in 3 quarters since.
  • 14 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.